Number of negative lymph nodes as a prognostic factor for ypN0-N1 breast cancer patients undergoing neoadjuvant chemotherapy

Factors Affecting Sentinel Lymph Node Identification Rate After Neoadjuvant Chemotherapy for Breast Cancer Patients Enrolled in ACOSOG Z1071 (Alliance)

(2015) Judy C. Boughey et al.   ANNALS OF SURGERY

Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer

(2015) San-Gang Wu et al.   BMC CANCER

Post-mastectomy radiotherapy after neodjuvant chemotherapy in breast cancer patients: A review

(2015) Jacques Bernier   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

PO-0669: Adjuvant chemotherapy improves outcome in NPC patients with post-RT persistently detectable plasma EBV DNA

(2015) C.T. Wu et al.   RADIOTHERAPY AND ONCOLOGY

DEGRO practical guidelines for radiotherapy of breast cancer IV

(2014) Frederik Wenz et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Timing of Determining Axillary Lymph Node Status When Neoadjuvant Chemotherapy is Used

(2014) Eleftherios P. Mamounas   Current Oncology Reports

The prognostic value of the number of lymph nodes removed in patients with node-negative colorectal cancer

(2014) Nüvit Duraker et al.   International Journal of Surgery

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection

(2013) Po-Kuei Hsu et al.   ANNALS OF THORACIC SURGERY

Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients

(2013) Ying Chen et al.   Cancer Cell International

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

(2013) Thorsten Kuehn et al.   LANCET ONCOLOGY

Neoadjuvant chemotherapy for breast cancer: any progress?

(2013) Marco Colleoni et al.   LANCET ONCOLOGY

The Number of Resected Lymph Nodes (nLNs) Combined with Tumor Size as a Prognostic Factor in Patients with Pathologic N0 and Nx Non-Small Cell Lung Cancer

(2013) Miaomiao Yang et al.   PLoS One

Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27

(2012) Eleftherios P. Mamounas et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients

(2011) Xiangnan Kong et al.   EUROPEAN JOURNAL OF CANCER

The Prognostic Significance of the Lymph Node Ratio in Axillary Lymph Node Positive Breast Cancer

(2011) Ji-Yoon Kim et al.   Journal of Breast Cancer

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

(2010) David N Krag et al.   LANCET ONCOLOGY

Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer

(2009) Hassan A. Hatoum et al.   ANNALS OF SURGICAL ONCOLOGY